Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 09, 2023

SELL
$5.09 - $9.05 $69,468 - $123,514
-13,648 Reduced 38.46%
21,840 $122,000
Q3 2022

Nov 10, 2022

SELL
$3.5 - $7.2 $1.78 Million - $3.65 Million
-507,267 Reduced 93.46%
35,488 $228,000
Q2 2022

Aug 12, 2022

BUY
$2.7 - $7.62 $200,998 - $567,263
74,444 Added 15.9%
542,755 $1.86 Million
Q1 2022

May 13, 2022

BUY
$6.3 - $8.84 $2.95 Million - $4.14 Million
468,311 New
468,311 $3.33 Million

Others Institutions Holding MCRB

About Seres Therapeutics, Inc.


  • Ticker MCRB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,072,000
  • Market Cap $89.3M
  • Description
  • Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...
More about MCRB
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.